For the year ended June 30, Aspen recorded a headline earnings per share of 14.05 rand, down from 14.61 rand a year earlier.
(Reporting by Promit Mukherjee; editing by Jason Neely)
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
230.2 ZAR | +0.64% | +1.57% | +13.13% |
Mar. 08 | Aspen Pharmacare Holdings Limited Announces Board Changes | CI |
Mar. 05 | Aspen Pharmacare Holdings Limited Seeks Acquisitions | CI |
JOHANNESBURG (Reuters) - South African drugmaker Aspen Pharmacare on Wednesday posted a 4% drop in annual profit impacted by higher inflation and a drop in COVID-19 vaccine sales.
For the year ended June 30, Aspen recorded a headline earnings per share of 14.05 rand, down from 14.61 rand a year earlier.
(Reporting by Promit Mukherjee; editing by Jason Neely)
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
230.2 ZAR | +0.64% | +1.57% | 5.55B | ||
149.9 USD | +0.04% | +0.43% | 361B | ||
1st Jan change | Capi. | |
---|---|---|
+13.13% | 5.55B | |
+19.62% | 43.27B | |
+24.52% | 22.92B | |
+20.29% | 15.43B | |
+7.48% | 12.95B | |
+42.51% | 11.83B | |
-8.84% | 6.91B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+9.14% | 4.9B |